Literature DB >> 19539966

CD8+ T cell immunodominance shifts during the early stages of acute LCMV infection independently from functional avidity maturation.

Hans-Peter Raué1, Mark K Slifka.   

Abstract

Virus-specific T cell responses are often directed to a small subset of possible epitopes and their relative magnitude defines their hierarchy. We determined the size and functional avidity of 4 representative peptide-specific CD8(+) T cell populations in C57BL/6 mice at different time points after lymphocytic choriomeningitis virus (LCMV) infection. We found that the frequency of different peptide-specific T cell populations in the spleen changed independently over the first 8 days after infection. These changes were not associated with a larger or more rapid increase in functional avidity and yet still resulted in a shift in the final immunodominance hierarchy. Thus, the immunodominance observed at the peak of an antiviral T cell response is not necessarily determined by the initial size or rate of functional avidity maturation of peptide-specific T cell populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539966      PMCID: PMC2728041          DOI: 10.1016/j.virol.2009.05.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.

Authors:  C C Bergmann; J D Altman; D Hinton; S A Stohlman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

3.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

4.  Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

Authors:  R G van der Most; R J Concepcion; C Oseroff; J Alexander; S Southwood; J Sidney; R W Chesnut; R Ahmed; A Sette
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.

Authors:  R G van der Most; A Sette; C Oseroff; J Alexander; K Murali-Krishna; L L Lau; S Southwood; J Sidney; R W Chesnut; M Matloubian; R Ahmed
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

Review 6.  T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases.

Authors:  A Weiss
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

7.  Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.

Authors:  J H Hanke; J P Gardner; R L Dow; P S Changelian; W H Brissette; E J Weringer; B A Pollok; P A Connelly
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire.

Authors:  K Daly; P Nguyen; D L Woodland; M A Blackman
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens.

Authors:  C E Rudd; E K Barber; K E Burgess; J Y Hahn; A D Odysseos; M S Sy; S F Schlossman
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

10.  Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs.

Authors:  L J McHeyzer-Williams; J F Panus; J A Mikszta; M G McHeyzer-Williams
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  7 in total

1.  In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Authors:  Beth C Holbrook; Rama D Yammani; Lance K Blevins; Martha A Alexander-Miller
Journal:  Viral Immunol       Date:  2013-08-24       Impact factor: 2.257

2.  Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine.

Authors:  Joshua M Walker; Hans-Peter Raué; Mark K Slifka
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

Authors:  Anthony D D'Souza; Ian A Parish; Sharen E McKay; Susan M Kaech; Gerald S Shadel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

4.  Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection.

Authors:  Samuel Amoah; Rama D Yammani; Jason M Grayson; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

5.  Quantifying T lymphocyte turnover.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-01-09       Impact factor: 2.691

6.  Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.

Authors:  Pascal Lapierre; Valérie Janelle; Marie-Pierre Langlois; Esther Tarrab; Tania Charpentier; Alain Lamarre
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-02-24

7.  Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia.

Authors:  Zoe L Lyski; Myung Sun Kim; David Xthona Lee; David Sampson; Hans-Peter Raué; Vikram Raghunathan; Debbie Ryan; Amanda E Brunton; Mark K Slifka; William B Messer; Stephen E Spurgeon
Journal:  Case Rep Hematol       Date:  2022-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.